Another condition, non-alcoholic fatty liver disease (NAFLD), occurs when fat is deposited in liver, steatosis, and lncRNAs, including H19 and its co-regulated protein-coding partner, IGF2, may play important roles in this disease progression. This evidence concerns the gene H19 and steatosis.